Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds NGM.
No tracked institution reports a position in NGM as of their last filing.
No one on the platform has traded NGM yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$NGM Absolute Failure of a Bio company. "Never Getting Money (NGM) "
View on StockTwits ↗IVDA is one of the only low-float stocks tied to AI surveillance, autonomous drones, and threat detection. If you think robotics, safety, and government tech will scale, you’re looking at one of the earliest and cheapest ways to play it. Zero hype. Max upside. $EYEN $PALI $LGVN $QNRX $NGM
View on StockTwits ↗@REBELSUN Well, $NGM is now delisted. $RAPT hasn’t done much lol
View on StockTwits ↗$NGM NGM Biopharmaceuticals, Inc. (NASDAQ:NGM): A Promising Biotech Tackling Unmet Medical Needs https://beyondspx.com/article/ngm-biopharmaceuticals-inc-nasdaq-ngm-a-promising-biotech-tackling-unmet-medical-needs
View on StockTwits ↗$NGM NGM Biopharmaceuticals, Inc. (NASDAQ:NGM): A Promising Biotech Tackling Unmet Medical Needs http://beyondspx.com/2024/08/05/ngm-biopharmaceuticals-inc-nasdaqngm-a-promising-biotech-tackling-unmet-medical-needs/
View on StockTwits ↗$NGM And that was that. There’s obviously things going on here that are way above my head. Time will tell exactly what, but I’m sure TCG and affiliates will be more than happy when payday comes.
View on StockTwits ↗$NGM NGM Bio Announces Closing of Tender Offer https://www.stocktitan.net/news/NGM/ngm-bio-announces-closing-of-tender-0cz420vju6fb.html
View on StockTwits ↗$NGM trade halt (T12) was alerted to our Members at 7:50pm EDT. Halt price: $1.55 Vol: 2.39M.
View on StockTwits ↗@Biotechster $NGM Holding out means missing a guaranteed profit, facing delisting risks, and losing liquidity when NGM Bio becomes a private company.
View on StockTwits ↗$NGM Any law firm which responds to this solicitation, I have information which may be relevant to your claims. Message me and my attorney will contact you….
View on StockTwits ↗$NGM NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting https://www.stocktitan.net/news/NGM/ngm-bio-to-present-two-posters-highlighting-clinical-data-from-the-6kycxr7ga5ij.html
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.